Description |
major histocompatibility complex, class II, DP beta 1 |
thyroid hormone receptor interactor 6 |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Acute graft versus host disease in bone marrow transplantation (recipient effect) ( 27595289)
- Anti-rubella virus IgG levels ( 30053915)
- Antineutrophil cytoplasmic antibody-associated vasculitis ( 28029757)
- Aspirin exacerbated respiratory disease in asthmatics ( 23180272)
- Asthma ( 31619474)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Blood protein levels ( 29875488)
- Chronic hepatitis B infection ( 24940741 25802187)
- Dermatomyositis ( 27153935)
- EGFR mutation-positive lung adenocarcinoma ( 27501781)
- Eosinophil percentage of granulocytes ( 27863252)
- Eosinophil percentage of white cells ( 27863252)
- Extranodal natural killer T-cell lymphoma (nasal type) ( 27470079)
- Gait speed in old age ( 28077804)
- Hepatitis B ( 21750111 19349983)
- Hepatitis B (viral clearance) ( 22737229)
- Hepatitis B vaccine response ( 21764829)
- IgA nephropathy ( 25305756)
- Monocyte count ( 27863252)
- Myositis ( 26291516)
- Nephropathy ( 21399633)
- Neutrophil count ( 32888494)
- Nodular sclerosis Hodgkin lymphoma ( 29196614)
- Plantar warts ( 28928442)
- Primary biliary cholangitis ( 28425483)
- Pulmonary arterial hypertension ( 30527956)
- Response to hepatitis B vaccine ( 31243853 29534301)
- Rosacea symptom severity ( 29771307)
- Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations) ( 26651848)
- Severe aplastic anemia ( 32004448)
- Sjögren's syndrome ( 24097066 28076899)
- Susceptibility to persistent hepatitis B virus infection ( 27244555)
- Systemic sclerosis ( 21779181)
- Thyrotoxic hypokalemic periodic paralysis and Graves disease ( 31050781)
- Wegener's granulomatosis ( 23740775)
- White blood cell count ( 32888494)
- White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure) ( 31044621)
|
- Bipolar disorder ( 31043756)
- Heart rate increase in response to exercise ( 29497042)
- Heart rate response to recovery post exercise (10 sec) ( 29497042)
- Heart rate response to recovery post exercise (20 sec) ( 29497042)
- Heart rate response to recovery post exercise (30 sec) ( 29497042)
- Heart rate response to recovery post exercise (40 sec) ( 29497042)
- Heart rate response to recovery post exercise (50 sec) ( 29497042)
- Nonunion in individuals with fractures ( 30680360)
- Plasminogen activator inhibitor type 1 levels (PAI-1) ( 22990020)
|
Interacting Genes |
8 interacting genes:
CD74
COPB1
HLA-DPA1
LZTS2
MEOX2
ROBO2
RTN4
TRIP6
|
164 interacting genes:
ABI2
ADAMTSL4
AQP1
ARNT2
ATN1
ATP23
ATP5PO
ATXN1
AXIN1
BAG3
BCAR1
BEX2
BYSL
C11orf87
CATSPER1
CBLC
CCDC120
CCDC187
CCDC24
CCL5
CEP57L1
CNTF
CREB5
CRYBA4
CTAG2
DHX37
DMRT3
DTX2
EFHC1
EPDR1
ERBB2
EXOC3-AS1
FAM124B
FAM222B
FARS2
FAS
FASLG
FHL3
FOXD4L1
FRS3
GAD1
GATA1
GDPD5
GFI1B
GLIS3
GNAI2
GNE
GPS2
GSE1
HCK
HLA-DPB1
HOXA1
HOXA9
HOXB9
HOXC8
HYKK
IL16
ILF3
INCA1
IP6K3
IQCN
ITGB4
KCTD9
KIF1A
KIR2DL4
KLK15
KPRP
KRTAP26-1
LMO2
LNX1
LPAR2
MAPKBP1
MEMO1
METTL17
MIEN1
MIIP
MISP
MSRB3
MVP
NCK2
NEDD9
NEU4
NOL4L-DT
NR1D2
NSMF
NUP210
ODF1
OIP5
OTUB2
OTX1
PATZ1
PDGFRB
PDLIM4
PER1
PIGS
PIN1
PLEKHN1
POM121
POM121L4P
PPP1R16A
PRKAA1
PRKAA2
PTK2
PTPN13
PTPN14
PXN
RAD23A
RANBP3L
RERE
RFX3
RHOA
RHOQ
RNF213
RNF214
SAXO1
SCAND1
SCRIB
SETDB1
SHISA6
SIK3
SLC15A3
SLC25A6
SMAD1
SMG9
SNAI1
SON
SRC
STAC
STK16
SVIL
SYNGAP1
TAB1
TBC1D22B
TCAF1
TEKT4
TENT5C
THRB
TIE1
TLE5
TLR2
TMSB4X
TPM3
TPM4
TRAF3IP2
TRAPPC2L
TRIM29
TSGA10IP
TSSK3
TTC23
TTLL10
TXN2
TXNDC5
USP2
VASN
VCL
WT1-AS
YPEL3
ZBP1
ZIC1
ZNF541
ZNF580
ZNF581
ZNF688
ZNF785
|
Entrez ID |
3115 |
7205 |
HPRD ID |
00832 |
04242 |
Ensembl ID |
ENSG00000223865
|
ENSG00000087077
|
Uniprot IDs |
I4EC15
P04440
|
Q15654
|
PDB IDs |
3LQZ
4P4K
4P4R
4P57
4P5K
4P5M
|
1X61
2DLO
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|